1. Home
  2. MSBI vs FBRX Comparison

MSBI vs FBRX Comparison

Compare MSBI & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Midland States Bancorp Inc.

MSBI

Midland States Bancorp Inc.

HOLD

Current Price

$21.90

Market Cap

456.2M

Sector

Finance

ML Signal

HOLD

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$31.49

Market Cap

367.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSBI
FBRX
Founded
1881
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
456.2M
367.4M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
MSBI
FBRX
Price
$21.90
$31.49
Analyst Decision
Hold
Strong Buy
Analyst Count
3
4
Target Price
$19.67
$67.00
AVG Volume (30 Days)
177.9K
221.0K
Earning Date
01-22-2026
11-14-2025
Dividend Yield
5.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$210,718,000.00
N/A
Revenue This Year
$28.14
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.24
$4.90
52 Week High
$25.76
$33.61

Technical Indicators

Market Signals
Indicator
MSBI
FBRX
Relative Strength Index (RSI) 66.68 68.07
Support Level $21.58 $23.11
Resistance Level $22.21 $27.65
Average True Range (ATR) 0.49 3.49
MACD -0.12 0.39
Stochastic Oscillator 65.46 88.41

Price Performance

Historical Comparison
MSBI
FBRX

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Share on Social Networks: